Models with ApoA1 and ApoB | ||||
---|---|---|---|---|
Outcome: CIMT | Outcome: Framingham score | |||
Variables | Coefficient (95% CI) | P-value | Coefficient (95% CI) | P-value |
Age, continuous | 0.00 (-0.00 – 0.00) | 0.173 | 0.11 (0.07 – 0.16) | <0.001 |
Body Mass Index, continuous | 0.00 (-0.00 – 0.00) | 0.441 | 0.05 (-0.00 – 0.11) | 0.057 |
Diabetes Mellitus, yes | 0.05 (0.02 – 0.08) | 0.001 | 3.03 (2.52 – 3.54) | <0.001 |
ApoA1, continuous | -0.00 (-0.05 – 0.04) | 0.959 | -3.25 (-4.13 – -2.37) | <0.001 |
ApoB, continuous | 0.01 (-0.04 – 0.05) | 0.754 | 6.139 (5.32 – 6.96) | <0.001 |
Visit | -0.01 (-0.02 – -0.00) | 0.019 | -0.07 (-0.20 – 0.06) | 0.288 |
Models with individual lipoprotein subfractions (without ApoA1 or ApoB) | ||||
Age, continuous | 0.00 (-0.00 – 0.00) | 0.170 | 0.10 (0.06 – 0.15) | <0.001 |
Body Mass Index, continuous | 0.00 (0.01 – 0.00) | 0.569 | 0.01 (-0.04 – 0.06) | 0.718 |
Diabetes Mellitus, yes | 0.05 (0.02 – 0.08) | 0.002 | 2.94 (2.45 – 3.43) | <0.001 |
VLDL | -0.00 (-0.00 – 0.00) | 0.942 | 0.01 (-0.02 – 0.32) | 0.675 |
IDL-C | -0.00 (-0.00 – 0.00) | 0.163 | 0.03 (-0.01 – 0.07) | 0.189 |
IDL-B | 0.00 (-0.00 – 0.00) | 0.193 | 0.02 (-0.03 – 0.07) | 0.426 |
IDL-A | -0.00 (-0.00 – 0.00) | 0.827 | 0.05 (0.02 – 0.08) | 0.002 |
Large LDL (1-2) | 0.00 (-0.00 – 0.00) | 0.442 | 0.036 (0.02 – 0.05) | <0.001 |
Small dense LDL (3-7) | 0.00 (-0.00 – 0.00) | 0.962 | -0.01 (-0.06 – 0.04) | 0.764 |
Large HDL | 0.00 (-0.00 – 0.00) | 0.631 | -0.10 (-0.16 – -0.05) | <0.001 |
Intermediate HDL | -0.00 (-0.01 – 0.00) | 0.187 | -0.13 (-0.19 – -0.07) | <0.001 |
Small HDL | 0.00 (-0.00 – 0.01) | 0.497 | -0.03 (-0.10 – 0.05) | 0.484 |
Visit | -0.01 (-0.02 – -0.00) | 0.015 | -0.08 (-0.21 – 0.05) | 0.245 |